» Articles » PMID: 19958431

Different Therapeutic Modalities for Treatment of Melasma

Overview
Specialty Dermatology
Date 2009 Dec 5
PMID 19958431
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chemical peels and topical depigmenting agents have become a popular modality in the treatment of melasma.

Aims: To compare the clinical efficacy of trichloroacetic acid peel 20%vs. Jessner's solution peel vs. the topical mixture of hydroquinone 2% and kojic acid.

Patients And Methods: Forty five patients with melasma were randomly assigned into three groups of fifteen patients each. Group A received Jessner's solution peel, group B received trichloroacetic acid peel 20%, and group C received topical hydroquinone 2% and kojic acid. All patients were seen in follow-up period after 16 weeks; clinical evaluation using Melasma Area and Severity Index (MASI) score and photography were recorded before and after treatment and after 16 weeks.

Results: There was a decrease in MASI score in all three groups after treatment and after follow-up period but after treatment MASI score was statistically significantly lower in group A than group C (P = 0.01), and it was also statistically significantly lower in group B than group C (P < 0.001) but there was no statistically significant difference between groups A and B. After the follow-up period, MASI score was statistically significantly lower in group A than group C (P < 0.001), statistically significantly lower in group B than group C (P < 0.001), and statistically significantly lower in group B than group A (P = 0.035). The statistical analysis was done through one-way anova followed by least significant difference (LSD).

Conclusion: Trichloroacetic acid 20% showed better results than Jessner's solution as peeling agent and hydroquinone 2% with kojic acid as a topical agent in the treatment of melasma.

Citing Articles

Topical and Systemic Therapies in Melasma: A Systematic Review.

Sarkar R, Handog E, Das A, Bansal A, Macarayo M, Keshavmurthy V Indian Dermatol Online J. 2023; 14(6):769-781.

PMID: 38099013 PMC: 10718129. DOI: 10.4103/idoj.idoj_490_22.


Update on Melasma-Part II: Treatment.

Cassiano D, Esposito A, da Silva C, Lima P, Dias J, Hassun K Dermatol Ther (Heidelb). 2022; 12(9):1989-2012.

PMID: 35906506 PMC: 9464276. DOI: 10.1007/s13555-022-00780-4.


Dermatology: how to manage facial hyperpigmentation in skin of colour.

Moolla S, Miller-Monthrope Y Drugs Context. 2022; 11.

PMID: 35720052 PMC: 9165630. DOI: 10.7573/dic.2021-11-2.


Low-power Fractional Carbon Dioxide Laser Followed by Jessner's Peel versus Jessner's Peel Alone for the Treatment of Melasma.

Elmorsy E, Aboukhadr N, Tayyeb M, Taha A J Clin Aesthet Dermatol. 2021; 14(2):61-67.

PMID: 34221230 PMC: 8211337.


Melasma Treatment: An Evidence-Based Review.

McKesey J, Tovar-Garza A, Pandya A Am J Clin Dermatol. 2019; 21(2):173-225.

PMID: 31802394 DOI: 10.1007/s40257-019-00488-w.